U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

mRNAs and miRNAs for Women's Healthy Eating and Living (WHEL) Study

(Submitter supplied) The nCounter miRGE™ assay was used to quantify transcript expression with a custom codeset containing probes for 123 endogenous mRNAs and 25 miRNAs to assess the association of genomic markers with long-term breast cancer survival. A total of 1,253 FFPE primary breast cancer samples with high-quality reads were obtained.
Organism:
Homo sapiens
Type:
Other
Platform:
GPL28286
1253 Samples
Download data: RCC, TXT
Series
Accession:
GSE147126
ID:
200147126
2.

Expression data from fine-needle aspiration biopsies of breast cancer metastases from different anatomical sites

(Submitter supplied) To determine whether breast cancer molecular subtypes and tumor characteristics with demonstrated significance in a primary tumor setting can also confer clinically relevant information in breast cancer metastases. We assessed previously published gene expression modules of seven biological processes and the intrinsic subtypes (PAM50). The translational aspect of the Swedish randomized TEX trial included 112 patients with at least one biopsy from morphologically confirmed loco-regional or distant breast cancer metastasis diagnosed from December 2002 until June 2007. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10379
120 Samples
Download data: CEL
Series
Accession:
GSE56493
ID:
200056493
3.

A nested case-control study to investigate drivers for metastatic disease in breast cancer

(Submitter supplied) The purpose of this study was to improve prediction of patients at high-risk for metastatic disease utilizing a nested case-control design that uniquely enables enrichment for relevant phenotypes. We identified all women diagnosed with primary breast cancer from January 1, 1997, to December 31, 2005, in the Stockholm health care region. Patients developing distant metastatic disease (cases) were selected and controls (free from distant disease) were randomly matched by adjuvant therapy, age and calendar period at diagnosis. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10379
623 Samples
Download data: CEL
Series
Accession:
GSE48091
ID:
200048091
4.

An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival

(Submitter supplied) The biological tumor samples (ie, breast tumor specimens) consisted of freshly frozen breast tumors from a population-based cohort of 315 women representing 65% of all breast cancers resected in Uppsala County, Sweden, from January 1, 1987 to December 31, 1989. Estrogen receptor status was determined by biochemical assay as part of the routine clinical procedure. An experienced pathologist determined the Elston-Ellis grades of the tumors, classifying the tumors into low, medium and high-grade tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL97 GPL96
502 Samples
Download data: CEL
Series
Accession:
GSE3494
ID:
200003494
5.

Intrinsic subtype and gene expression changes between matched primary and metastatic samples of breast cancer patients

(Submitter supplied) We compared expression of 105 breast cancer-related genes between matched primary and metastatic breast cancer
Organism:
Homo sapiens
Type:
Other
Platform:
GPL17071
246 Samples
Download data: TXT
Series
Accession:
GSE92977
ID:
200092977
6.

RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer

(Submitter supplied) BACKGROUND: We characterized the whole transcriptome of circulating tumor cells (CTCs) in Stage II-III breast cancer to evaluate correlations with primary tumor biology. METHODS: CTCs were isolated from peripheral blood (PB) via immunomagnetic enrichment followed by fluorescence-activated cell sorting (IE-FACS). CTCs, PB and fresh tumors were profiled with RNA Seq. Formalin-fixed, paraffin-embedded (FFPE) tumors were subjected to RNA Seq and NanoString PAM50 assays with Risk of Recurrence (ROR) scores. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL16791
34 Samples
Download data: TXT
Series
Accession:
GSE111842
ID:
200111842
7.

A consensus hypoxia signature in breast cancer

(Submitter supplied) We exposed a panel of 32 breast cancer cell lines or normal human mammary epithelial cells to 20% or 1% O2 concentration for 24h. Total RNA was extracted from cells using TRIzol (Invitrogen) and treated with DNase I (Ambion). All samples had a RIN value of >9.0 when measured on an Agilent Bioanalyzer. Libraries for RNA-Seq were prepared with KAPA Stranded RNA-Seq Kit. The workflow consisted of mRNA enrichment, cDNA generation, end repair to generate blunt ends, A-tailing, adaptor ligation and 12 cycles of PCR amplification. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL20301
64 Samples
Download data: CSV
8.

Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with chemotherapy plus trastuzumab and lapatinib as neoadjuvant therapy for HER2-positive breast cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Genome variation profiling by SNP array
Platforms:
GPL6801 GPL570
156 Samples
Download data: CEL, CNCHP
Series
Accession:
GSE66399
ID:
200066399
9.

Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer

(Submitter supplied) Prognostication of Breast Cancer (BC) relies largely on traditional markers such as hormone or growth factors but due to their suboptimal specificities, it is challenging to identify the subset of patients who are likely to undergo recurrence and markers of higher specificity are sought to guide therapies. MicroRNAs (miRNAs) are small non-coding RNAs which function as post-transcriptional regulators of gene expression and have shown promise as potential prognostic markers in several cancer types including BC. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL10999
114 Samples
Download data: TXT
10.

Gene expression analysis of CALGB 9741 patient tumor samples using the nCounter RUO-PAM50 signature

(Submitter supplied) Intrinsic subtyping of breast cancer was performed using an nCounter RUO-PAM50 gene expression assay to determine the ability of instrinsic subtyping to predict what patients may benefit from altered chemotherapy scheduling in the CALGB 9741 clinical trial population.
Organism:
Homo sapiens
Type:
Other
Platform:
GPL21114
1321 Samples
Download data: RCC
Series
Accession:
GSE74821
ID:
200074821
11.

Assessment of tumor pathological and transcriptional biomarkers in pre- and on-treatment core biopsies predictive of response and outcome after neoadjuvant chemotherapy plus Bevacizumab in patients with HER2-negative breast cancer

(Submitter supplied) Assessment of tumor pathological and transcriptional biomarkers in pre- and on-treatment core biopsies predictive of response and outcome after neoadjuvant chemotherapy plus Bevacizumab in patients with HER2-negative breast cancer: Results from a multi-center, single-arm, phase 2 study (the PROMIX trial) Global gene expression profiling was performed on samples from 3 time points (baseline, after 2 cycles and surgery) from women with breast cancer receivcing neoadjuvant chemotherapy with bevacizumab in a phase 2 trial
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
275 Samples
Download data: TXT
Series
Accession:
GSE87455
ID:
200087455
12.

Quantitative reverse transcription PCR analysis of human breast tumor cells in the PAM50 genes

(Submitter supplied) Human formalin-fixed paraffin-embedded breast tumor tissue (1-4 1.5mm punches) was processed to RNA using High Pure RNA Paraffin Kit (Roche Applied Science, Indianapolis, IN) for quantitative reverse transcription polymerase chain reaction (qRT-PCR).
Organism:
Homo sapiens
Type:
Expression profiling by RT-PCR
Platform:
GPL24747
246 Samples
Download data: TXT
Series
Accession:
GSE112063
ID:
200112063
13.

Evaluation of Invasive Breast Cancer Using a 12-Chemokine Gene Expression Score: Correlation With Clinical Outcomes

(Submitter supplied) Clinically annotated GEPs of 366 primary resected breast tumors ranked by a 12 gene chemokine score
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL15048
366 Samples
Download data: CEL
Series
Accession:
GSE86166
ID:
200086166
14.

Tumor & Tumor-Adj Gene Expression in the Nurses' Health Study Cohorts

(Submitter supplied) Gene expression data from the Nurses' Health Study
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing; Third-party reanalysis
Platforms:
GPL22920 GPL17585
1577 Samples
Download data: CEL, CSV, TXT
Series
Accession:
GSE115577
ID:
200115577
15.

Concordance of PAM50 molecular subtyping between oligonucleotide microarray and NanoString nCounter assay for Taiwanese breast cancer

(Submitter supplied) Five molecular subtypes have been identified according to intrinsic genes transcription. Microarrays have been adopted for molecular subtyping in addition to the original NanoString nCounter assay. This study aimed to evaluate subtyping consistency among Taiwanese breast cancers. Our study showed that fundamental discrepancy exists between distinct gene expression measuring approaches, and cross platform equivalence should not be overemphasized with too much extrapolation.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
133 Samples
Download data: CEL
Series
Accession:
GSE162228
ID:
200162228
16.

Gene Expression Signature of Microcalcification among Taiwanese Breast Cancer

(Submitter supplied) Microcalcification is one of the most common radiological and pathological features of breast ductal carcinoma in situ (DCIS), and to a lesser extent, invasive ductal carcinoma. We evaluated transcriptional profiles associated with ectopic mammary mineralization. We evaluated the transcriptional profiles associated with breast cancer microcalcification for Taiwanese breast cancer and a gene expression signature was derived.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
109 Samples
Download data: CEL
Series
Accession:
GSE146558
ID:
200146558
17.

Concurrent Gene Signatures for Han Chinese Breast Cancers

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Genome variation profiling by array
Platforms:
GPL570 GPL9075
104 Samples
Download data: CEL, TXT
Series
Accession:
GSE48391
ID:
200048391
18.

Concurrent Gene Signatures for Han Chinese Breast Cancers [Affymetrix]

(Submitter supplied) The interplay between copy number variation (CNV) and differential gene expression may be able to shed light on molecular process underlying breast cancer and lead to the discovery of cancer-related genes. In the current study, genes concurrently identified in array comparative genomic hybridization (CGH) and gene expression microarrays were used to derive gene signatures for Han Chinese breast cancers. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
81 Samples
Download data: CEL
Series
Accession:
GSE48390
ID:
200048390
19.

Concurrent Gene Signatures for Han Chinese Breast Cancers [Agilent]

(Submitter supplied) The interplay between copy number variation (CNV) and differential gene expression may be able to shed light on molecular process underlying breast cancer and lead to the discovery of cancer-related genes. In the current study, genes concurrently identified in array comparative genomic hybridization (CGH) and gene expression microarrays were used to derive gene signatures for Han Chinese breast cancers. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platform:
GPL9075
23 Samples
Download data: TXT
Series
Accession:
GSE48297
ID:
200048297
20.

Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling

(Submitter supplied) Accumulating evidence indicates that human circulating microRNAs (miRNAs) could serve as diagnostic and prognostic biomarkers in various cancers. We aimed to explore novel miRNA biomarkers in the blood of breast cancer patients based on miRNA profiling. A miRCURY™ LNA Array was used to identify differentially altered miRNAs in the whole blood of breast cancer patients (n = 6) and healthy controls (n = 6). more...
Organism:
synthetic construct; Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL22003
12 Samples
Download data: GPR, TXT
Series
Accession:
GSE83270
ID:
200083270
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_674f91de68e51b28f583ca75|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center